APA (7th ed.) Citation

Rodrigues, M., Vanoni, G., Loap, P., Dubot, C., Timperi, E., Minsat, M., . . . Romano, E. (2023). Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: The NICOL phase 1 trial. Nature communications, 14(1), 3698-15. https://doi.org/10.1038/s41467-023-39383-8

Chicago Style (17th ed.) Citation

Rodrigues, Manuel, et al. "Nivolumab Plus Chemoradiotherapy in Locally-advanced Cervical Cancer: The NICOL Phase 1 Trial." Nature Communications 14, no. 1 (2023): 3698-15. https://doi.org/10.1038/s41467-023-39383-8.

MLA (9th ed.) Citation

Rodrigues, Manuel, et al. "Nivolumab Plus Chemoradiotherapy in Locally-advanced Cervical Cancer: The NICOL Phase 1 Trial." Nature Communications, vol. 14, no. 1, 2023, pp. 3698-15, https://doi.org/10.1038/s41467-023-39383-8.